Results 141 to 150 of about 677,670 (306)
Effect of chemotherapy on passenger mutations in metastatic colorectal cancer
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui +6 more
wiley +1 more source
Best Practices for Machine Learning-Assisted Protein Engineering. [PDF]
Herrera-Rocha F +4 more
europepmc +1 more source
PEBank: A Comprehensive Database for Protein Engineering and Design [PDF]
Connie Wang +4 more
openalex +1 more source
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
Protein Engineering and Drug Discovery: Importance, Methodologies, Challenges, and Prospects. [PDF]
Mohammed A, Ibrahim NA, Basher NS.
europepmc +1 more source
Genetic Engineering on <i>Bacillus thuringiensis</i> Insecticidal Proteins
Keiko Nakamura, Yoshiyasu Yabusaki
openalex +2 more sources
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
Structural and functional insights into internal domain replacement in SpCas9 for protein engineering. [PDF]
Kim S +7 more
europepmc +1 more source
Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody [PDF]
Céline Monnet +12 more
openalex +1 more source

